SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-23-000140
Filing Date
2023-11-02
Accepted
2023-11-02 09:20:31
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20230930.htm   iXBRL 10-Q 1330468
2 EX-31.1 exhibit31-1x09x30x23.htm EX-31.1 9704
3 EX-31.2 exhibit31-2x09x30x23.htm EX-31.2 9715
4 EX-32.1 exhibit32-1x09x30x23.htm EX-32.1 4702
5 EX-32.2 exhibit32-2x09x30x23.htm EX-32.2 4697
  Complete submission text file 0001439222-23-000140.txt   5985536

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20230930.xsd EX-101.SCH 40058
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20230930_cal.xml EX-101.CAL 71025
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20230930_def.xml EX-101.DEF 153135
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20230930_lab.xml EX-101.LAB 577923
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20230930_pre.xml EX-101.PRE 366694
61 EXTRACTED XBRL INSTANCE DOCUMENT agio-20230930_htm.xml XML 756725
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 231370382
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences